Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic Article Swipe
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.7196/samj.2022.v112i8.16473
Background. Ivermectin is an antiparasitic drug that has shown in vitro activity against COVID‑19. Clinical studies supporting ivermectin for COVID‑19 prevention and treatment are conflicting, with important limitations. Public support for ivermectin is significant, with extensive off-label use despite the conflicting views on its efficacy. Ivermectin tablets and injectable formulations are not registered in South Africa for human use by the South African Health Products Regulatory Authority. The National Department of Health does not currently recommend the use of ivermectin for COVID‑19.Objectives. To describe cases of ivermectin exposure reported to the Poisons Information Helpline of the Western Cape (PIHWC) before and after publication of the drug’s in vitro activity against SARS-CoV-2.Methods. In a retrospective review, ivermectin-related calls reported to the PIHWC from 1 June 2015 to 30 June 2020 (period 1) were compared with calls received from 1 July 2020 to 31 July 2021 (period 2), dichotomised according to the first publication indicating ivermectin activity against SARS-CoV-2.Results. Seventy-one cases were screened, and 65 were included for analysis; 19 cases were reported during period 1 and 46 during period 2. During period 2, 25 ivermectin cases (54.3%) were related to COVID‑19 use. Of these, 24 cases (52.2%) involved veterinary preparations, 3 (6.5%) human preparations and 19 (41.3%) unknown preparations. Fourteen cases (73.7%) during period 1 and 30 (65.2%) during period 2 were reported to be symptomatic. The most common organ systems involved were the central nervous (n=26 cases; 40.0%), gastrointestinal (n=18; 27.7%), ocular (n=9; 13.8%) and dermatological (n=5; 7.7%) systems.Conclusion. Ivermectin-related exposure calls increased during study period 2, probably as a result of ivermectin being used as preventive and definitive therapy for COVID‑19 in the absence of robust evidence on efficacy, dosing recommendations or appropriate formulations.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.7196/samj.2022.v112i8.16473
- https://samajournals.co.za/index.php/samj/article/download/99/77
- OA Status
- gold
- Cited By
- 2
- References
- 19
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4289517948
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4289517948Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.7196/samj.2022.v112i8.16473Digital Object Identifier
- Title
-
Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemicWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-08-02Full publication date if available
- Authors
-
Veshni Pillay-Fuentes Lorente, G Voigt, C E Du Plessis, K Balme, Carine Marks, Eric Decloedt, Cindy Stephen, Helmuth Reuter, Roland van RensburgList of authors in order
- Landing page
-
https://doi.org/10.7196/samj.2022.v112i8.16473Publisher landing page
- PDF URL
-
https://samajournals.co.za/index.php/samj/article/download/99/77Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://samajournals.co.za/index.php/samj/article/download/99/77Direct OA link when available
- Concepts
-
Ivermectin, Medicine, Antiparasitic agent, Pandemic, Public health, Veterinary medicine, Coronavirus disease 2019 (COVID-19), Internal medicine, Disease, Pathology, Infectious disease (medical specialty)Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
19Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4289517948 |
|---|---|
| doi | https://doi.org/10.7196/samj.2022.v112i8.16473 |
| ids.doi | https://doi.org/10.7196/samj.2022.v112i8.16473 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36214394 |
| ids.openalex | https://openalex.org/W4289517948 |
| fwci | 0.25036359 |
| mesh[0].qualifier_ui | Q000627 |
| mesh[0].descriptor_ui | D000977 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | therapeutic use |
| mesh[0].descriptor_name | Antiparasitic Agents |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000086382 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | COVID-19 |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D007559 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Ivermectin |
| mesh[4].qualifier_ui | Q000517 |
| mesh[4].descriptor_ui | D058873 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | prevention & control |
| mesh[4].descriptor_name | Pandemics |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011042 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Poisons |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D000086402 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | SARS-CoV-2 |
| mesh[7].qualifier_ui | Q000453 |
| mesh[7].descriptor_ui | D013019 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | epidemiology |
| mesh[7].descriptor_name | South Africa |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D000977 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Antiparasitic Agents |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000086382 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | COVID-19 |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000627 |
| mesh[11].descriptor_ui | D007559 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | therapeutic use |
| mesh[11].descriptor_name | Ivermectin |
| mesh[12].qualifier_ui | Q000517 |
| mesh[12].descriptor_ui | D058873 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | prevention & control |
| mesh[12].descriptor_name | Pandemics |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D011042 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Poisons |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D000086402 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | SARS-CoV-2 |
| mesh[15].qualifier_ui | Q000453 |
| mesh[15].descriptor_ui | D013019 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | epidemiology |
| mesh[15].descriptor_name | South Africa |
| type | article |
| title | Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic |
| biblio.issue | 8 |
| biblio.volume | 112 |
| biblio.last_page | 525 |
| biblio.first_page | 522 |
| topics[0].id | https://openalex.org/T11702 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9958999752998352 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | Parasitic Diseases Research and Treatment |
| topics[1].id | https://openalex.org/T12116 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9889000058174133 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | Dermatological diseases and infestations |
| topics[2].id | https://openalex.org/T12663 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.9074000120162964 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3203 |
| topics[2].subfield.display_name | Clinical Psychology |
| topics[2].display_name | Body Image and Dysmorphia Studies |
| is_xpac | False |
| apc_list.value | 5732 |
| apc_list.currency | ZAR |
| apc_list.value_usd | 311 |
| apc_paid.value | 5732 |
| apc_paid.currency | ZAR |
| apc_paid.value_usd | 311 |
| concepts[0].id | https://openalex.org/C2777499811 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9763330221176147 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q415178 |
| concepts[0].display_name | Ivermectin |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.6155582666397095 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2911037157 |
| concepts[2].level | 2 |
| concepts[2].score | 0.602191150188446 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q581102 |
| concepts[2].display_name | Antiparasitic agent |
| concepts[3].id | https://openalex.org/C89623803 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5334653258323669 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[3].display_name | Pandemic |
| concepts[4].id | https://openalex.org/C138816342 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4474961459636688 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q189603 |
| concepts[4].display_name | Public health |
| concepts[5].id | https://openalex.org/C42972112 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4187558889389038 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q170201 |
| concepts[5].display_name | Veterinary medicine |
| concepts[6].id | https://openalex.org/C3008058167 |
| concepts[6].level | 4 |
| concepts[6].score | 0.34829890727996826 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[6].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.1690121293067932 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C2779134260 |
| concepts[8].level | 2 |
| concepts[8].score | 0.1387747824192047 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[8].display_name | Disease |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.08913946151733398 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| concepts[10].id | https://openalex.org/C524204448 |
| concepts[10].level | 3 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[10].display_name | Infectious disease (medical specialty) |
| keywords[0].id | https://openalex.org/keywords/ivermectin |
| keywords[0].score | 0.9763330221176147 |
| keywords[0].display_name | Ivermectin |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.6155582666397095 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/antiparasitic-agent |
| keywords[2].score | 0.602191150188446 |
| keywords[2].display_name | Antiparasitic agent |
| keywords[3].id | https://openalex.org/keywords/pandemic |
| keywords[3].score | 0.5334653258323669 |
| keywords[3].display_name | Pandemic |
| keywords[4].id | https://openalex.org/keywords/public-health |
| keywords[4].score | 0.4474961459636688 |
| keywords[4].display_name | Public health |
| keywords[5].id | https://openalex.org/keywords/veterinary-medicine |
| keywords[5].score | 0.4187558889389038 |
| keywords[5].display_name | Veterinary medicine |
| keywords[6].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[6].score | 0.34829890727996826 |
| keywords[6].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.1690121293067932 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/disease |
| keywords[8].score | 0.1387747824192047 |
| keywords[8].display_name | Disease |
| keywords[9].id | https://openalex.org/keywords/pathology |
| keywords[9].score | 0.08913946151733398 |
| keywords[9].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.7196/samj.2022.v112i8.16473 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S147026946 |
| locations[0].source.issn | 0256-9574, 2078-5135 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0256-9574 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | South African Medical Journal |
| locations[0].source.host_organization | https://openalex.org/P4310315351 |
| locations[0].source.host_organization_name | Health and Medical Publishing Group |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315351 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://samajournals.co.za/index.php/samj/article/download/99/77 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | South African Medical Journal |
| locations[0].landing_page_url | https://doi.org/10.7196/samj.2022.v112i8.16473 |
| locations[1].id | pmid:36214394 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36214394 |
| locations[2].id | pmh:oai:doaj.org/article:534e01961b754129af5a8bba54b34443 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | cc-by-sa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | https://openalex.org/licenses/cc-by-sa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | South African Medical Journal, Vol 112, Iss 8 (2022) |
| locations[2].landing_page_url | https://doaj.org/article/534e01961b754129af5a8bba54b34443 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5034655239 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5365-0320 |
| authorships[0].author.display_name | Veshni Pillay-Fuentes Lorente |
| authorships[0].countries | ZA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[0].institutions[0].id | https://openalex.org/I26092322 |
| authorships[0].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[0].institutions[0].country_code | ZA |
| authorships[0].institutions[0].display_name | Stellenbosch University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | V Pillay-Fuentes Lorente |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[1].author.id | https://openalex.org/A5017566685 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | G Voigt |
| authorships[1].countries | ZA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[1].institutions[0].id | https://openalex.org/I26092322 |
| authorships[1].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[1].institutions[0].country_code | ZA |
| authorships[1].institutions[0].display_name | Stellenbosch University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | G Voigt |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[2].author.id | https://openalex.org/A5109420851 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | C E Du Plessis |
| authorships[2].countries | ZA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[2].institutions[0].id | https://openalex.org/I26092322 |
| authorships[2].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[2].institutions[0].country_code | ZA |
| authorships[2].institutions[0].display_name | Stellenbosch University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | C E Du Plessis |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[3].author.id | https://openalex.org/A5047077246 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | K Balme |
| authorships[3].countries | ZA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I157614274, https://openalex.org/I4210157117 |
| authorships[3].affiliations[0].raw_affiliation_string | Red Cross War Memorial Children's Hospital and Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, South Africa |
| authorships[3].institutions[0].id | https://openalex.org/I4210157117 |
| authorships[3].institutions[0].ror | https://ror.org/04d6eav07 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I1307091933, https://openalex.org/I4210157117 |
| authorships[3].institutions[0].country_code | ZA |
| authorships[3].institutions[0].display_name | Red Cross War Memorial Children's Hospital |
| authorships[3].institutions[1].id | https://openalex.org/I157614274 |
| authorships[3].institutions[1].ror | https://ror.org/03p74gp79 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I157614274 |
| authorships[3].institutions[1].country_code | ZA |
| authorships[3].institutions[1].display_name | University of Cape Town |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | K Balme |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Red Cross War Memorial Children's Hospital and Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, South Africa |
| authorships[4].author.id | https://openalex.org/A5073104054 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9033-4212 |
| authorships[4].author.display_name | Carine Marks |
| authorships[4].countries | ZA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[4].institutions[0].id | https://openalex.org/I26092322 |
| authorships[4].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[4].institutions[0].country_code | ZA |
| authorships[4].institutions[0].display_name | Stellenbosch University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | C J Marks |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[5].author.id | https://openalex.org/A5089203897 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1815-5150 |
| authorships[5].author.display_name | Eric Decloedt |
| authorships[5].countries | ZA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[5].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[5].institutions[0].id | https://openalex.org/I26092322 |
| authorships[5].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[5].institutions[0].country_code | ZA |
| authorships[5].institutions[0].display_name | Stellenbosch University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | E H Decloedt |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[6].author.id | https://openalex.org/A5008682435 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0085-9515 |
| authorships[6].author.display_name | Cindy Stephen |
| authorships[6].countries | ZA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I157614274, https://openalex.org/I4210157117 |
| authorships[6].affiliations[0].raw_affiliation_string | Red Cross War Memorial Children's Hospital and Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, South Africa |
| authorships[6].institutions[0].id | https://openalex.org/I4210157117 |
| authorships[6].institutions[0].ror | https://ror.org/04d6eav07 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I1307091933, https://openalex.org/I4210157117 |
| authorships[6].institutions[0].country_code | ZA |
| authorships[6].institutions[0].display_name | Red Cross War Memorial Children's Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I157614274 |
| authorships[6].institutions[1].ror | https://ror.org/03p74gp79 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I157614274 |
| authorships[6].institutions[1].country_code | ZA |
| authorships[6].institutions[1].display_name | University of Cape Town |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | C Stephen |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Red Cross War Memorial Children's Hospital and Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Cape Town, South Africa |
| authorships[7].author.id | https://openalex.org/A5086135229 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4672-1412 |
| authorships[7].author.display_name | Helmuth Reuter |
| authorships[7].countries | ZA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[7].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[7].institutions[0].id | https://openalex.org/I26092322 |
| authorships[7].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[7].institutions[0].country_code | ZA |
| authorships[7].institutions[0].display_name | Stellenbosch University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | H Reuter |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[8].author.id | https://openalex.org/A5071740911 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-6464-4257 |
| authorships[8].author.display_name | Roland van Rensburg |
| authorships[8].countries | ZA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I26092322 |
| authorships[8].affiliations[0].raw_affiliation_string | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| authorships[8].institutions[0].id | https://openalex.org/I26092322 |
| authorships[8].institutions[0].ror | https://ror.org/05bk57929 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I26092322 |
| authorships[8].institutions[0].country_code | ZA |
| authorships[8].institutions[0].display_name | Stellenbosch University |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | R Van Rensburg |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://samajournals.co.za/index.php/samj/article/download/99/77 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Ivermectin exposures reported to the Poisons Information Helpline in South Africa during the COVID-19 pandemic |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11702 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9958999752998352 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | Parasitic Diseases Research and Treatment |
| related_works | https://openalex.org/W4387096075, https://openalex.org/W3089240778, https://openalex.org/W4386687691, https://openalex.org/W2028726649, https://openalex.org/W3206286458, https://openalex.org/W3186157209, https://openalex.org/W2016002411, https://openalex.org/W177093907, https://openalex.org/W3183181187, https://openalex.org/W3035077249 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.7196/samj.2022.v112i8.16473 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S147026946 |
| best_oa_location.source.issn | 0256-9574, 2078-5135 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0256-9574 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | South African Medical Journal |
| best_oa_location.source.host_organization | https://openalex.org/P4310315351 |
| best_oa_location.source.host_organization_name | Health and Medical Publishing Group |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315351 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://samajournals.co.za/index.php/samj/article/download/99/77 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | South African Medical Journal |
| best_oa_location.landing_page_url | https://doi.org/10.7196/samj.2022.v112i8.16473 |
| primary_location.id | doi:10.7196/samj.2022.v112i8.16473 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S147026946 |
| primary_location.source.issn | 0256-9574, 2078-5135 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0256-9574 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | South African Medical Journal |
| primary_location.source.host_organization | https://openalex.org/P4310315351 |
| primary_location.source.host_organization_name | Health and Medical Publishing Group |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315351 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://samajournals.co.za/index.php/samj/article/download/99/77 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | South African Medical Journal |
| primary_location.landing_page_url | https://doi.org/10.7196/samj.2022.v112i8.16473 |
| publication_date | 2022-08-02 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W4288400169, https://openalex.org/W3035026987, https://openalex.org/W2014301459, https://openalex.org/W3121596699, https://openalex.org/W3170319714, https://openalex.org/W4225677225, https://openalex.org/W3137582540, https://openalex.org/W2104930292, https://openalex.org/W3049024851, https://openalex.org/W3022811568, https://openalex.org/W3033658063, https://openalex.org/W2315025664, https://openalex.org/W3156439502, https://openalex.org/W3130495244, https://openalex.org/W3014962324, https://openalex.org/W3210440909, https://openalex.org/W3061335889, https://openalex.org/W3206068483, https://openalex.org/W3205237291 |
| referenced_works_count | 19 |
| abstract_inverted_index.1 | 122, 137, 173, 213 |
| abstract_inverted_index.2 | 219 |
| abstract_inverted_index.3 | 199 |
| abstract_inverted_index.a | 112, 259 |
| abstract_inverted_index.1) | 130 |
| abstract_inverted_index.19 | 167, 204 |
| abstract_inverted_index.2, | 181, 256 |
| abstract_inverted_index.2. | 178 |
| abstract_inverted_index.24 | 193 |
| abstract_inverted_index.25 | 182 |
| abstract_inverted_index.30 | 126, 215 |
| abstract_inverted_index.31 | 141 |
| abstract_inverted_index.46 | 175 |
| abstract_inverted_index.65 | 162 |
| abstract_inverted_index.In | 111 |
| abstract_inverted_index.Of | 191 |
| abstract_inverted_index.To | 82 |
| abstract_inverted_index.an | 3 |
| abstract_inverted_index.as | 258, 265 |
| abstract_inverted_index.be | 223 |
| abstract_inverted_index.by | 59 |
| abstract_inverted_index.in | 9, 53, 106, 272 |
| abstract_inverted_index.is | 2, 32 |
| abstract_inverted_index.of | 70, 78, 85, 94, 103, 261, 275 |
| abstract_inverted_index.on | 42, 278 |
| abstract_inverted_index.or | 282 |
| abstract_inverted_index.to | 89, 118, 125, 140, 148, 188, 222 |
| abstract_inverted_index.2), | 145 |
| abstract_inverted_index.The | 67, 225 |
| abstract_inverted_index.and | 21, 47, 100, 161, 174, 203, 214, 244, 267 |
| abstract_inverted_index.are | 23, 50 |
| abstract_inverted_index.for | 18, 30, 56, 80, 165, 270 |
| abstract_inverted_index.has | 7 |
| abstract_inverted_index.its | 43 |
| abstract_inverted_index.not | 51, 73 |
| abstract_inverted_index.the | 39, 60, 76, 90, 95, 104, 119, 149, 232, 273 |
| abstract_inverted_index.use | 37, 58, 77 |
| abstract_inverted_index.2015 | 124 |
| abstract_inverted_index.2020 | 128, 139 |
| abstract_inverted_index.2021 | 143 |
| abstract_inverted_index.Cape | 97 |
| abstract_inverted_index.July | 138, 142 |
| abstract_inverted_index.June | 123, 127 |
| abstract_inverted_index.does | 72 |
| abstract_inverted_index.drug | 5 |
| abstract_inverted_index.from | 121, 136 |
| abstract_inverted_index.most | 226 |
| abstract_inverted_index.that | 6 |
| abstract_inverted_index.use. | 190 |
| abstract_inverted_index.used | 264 |
| abstract_inverted_index.were | 131, 159, 163, 169, 186, 220, 231 |
| abstract_inverted_index.with | 25, 34, 133 |
| abstract_inverted_index.(n=26 | 235 |
| abstract_inverted_index.(n=5; | 246 |
| abstract_inverted_index.(n=9; | 242 |
| abstract_inverted_index.7.7%) | 247 |
| abstract_inverted_index.PIHWC | 120 |
| abstract_inverted_index.South | 54, 61 |
| abstract_inverted_index.after | 101 |
| abstract_inverted_index.being | 263 |
| abstract_inverted_index.calls | 116, 134, 251 |
| abstract_inverted_index.cases | 84, 158, 168, 184, 194, 209 |
| abstract_inverted_index.first | 150 |
| abstract_inverted_index.human | 57, 201 |
| abstract_inverted_index.organ | 228 |
| abstract_inverted_index.shown | 8 |
| abstract_inverted_index.study | 254 |
| abstract_inverted_index.views | 41 |
| abstract_inverted_index.vitro | 10, 107 |
| abstract_inverted_index.(6.5%) | 200 |
| abstract_inverted_index.(n=18; | 239 |
| abstract_inverted_index.13.8%) | 243 |
| abstract_inverted_index.Africa | 55 |
| abstract_inverted_index.During | 179 |
| abstract_inverted_index.Health | 63, 71 |
| abstract_inverted_index.Public | 28 |
| abstract_inverted_index.before | 99 |
| abstract_inverted_index.cases; | 236 |
| abstract_inverted_index.common | 227 |
| abstract_inverted_index.dosing | 280 |
| abstract_inverted_index.during | 171, 176, 211, 217, 253 |
| abstract_inverted_index.ocular | 241 |
| abstract_inverted_index.period | 172, 177, 180, 212, 218, 255 |
| abstract_inverted_index.result | 260 |
| abstract_inverted_index.robust | 276 |
| abstract_inverted_index.these, | 192 |
| abstract_inverted_index.(41.3%) | 205 |
| abstract_inverted_index.(52.2%) | 195 |
| abstract_inverted_index.(54.3%) | 185 |
| abstract_inverted_index.(65.2%) | 216 |
| abstract_inverted_index.(73.7%) | 210 |
| abstract_inverted_index.(PIHWC) | 98 |
| abstract_inverted_index.(period | 129, 144 |
| abstract_inverted_index.27.7%), | 240 |
| abstract_inverted_index.40.0%), | 237 |
| abstract_inverted_index.African | 62 |
| abstract_inverted_index.Poisons | 91 |
| abstract_inverted_index.Western | 96 |
| abstract_inverted_index.absence | 274 |
| abstract_inverted_index.against | 12, 109, 155 |
| abstract_inverted_index.central | 233 |
| abstract_inverted_index.despite | 38 |
| abstract_inverted_index.nervous | 234 |
| abstract_inverted_index.related | 187 |
| abstract_inverted_index.review, | 114 |
| abstract_inverted_index.studies | 15 |
| abstract_inverted_index.support | 29 |
| abstract_inverted_index.systems | 229 |
| abstract_inverted_index.tablets | 46 |
| abstract_inverted_index.therapy | 269 |
| abstract_inverted_index.unknown | 206 |
| abstract_inverted_index.Clinical | 14 |
| abstract_inverted_index.Fourteen | 208 |
| abstract_inverted_index.Helpline | 93 |
| abstract_inverted_index.National | 68 |
| abstract_inverted_index.Products | 64 |
| abstract_inverted_index.activity | 11, 108, 154 |
| abstract_inverted_index.compared | 132 |
| abstract_inverted_index.describe | 83 |
| abstract_inverted_index.drug’s | 105 |
| abstract_inverted_index.evidence | 277 |
| abstract_inverted_index.exposure | 87, 250 |
| abstract_inverted_index.included | 164 |
| abstract_inverted_index.involved | 196, 230 |
| abstract_inverted_index.probably | 257 |
| abstract_inverted_index.received | 135 |
| abstract_inverted_index.reported | 88, 117, 170, 221 |
| abstract_inverted_index.according | 147 |
| abstract_inverted_index.analysis; | 166 |
| abstract_inverted_index.currently | 74 |
| abstract_inverted_index.efficacy, | 279 |
| abstract_inverted_index.efficacy. | 44 |
| abstract_inverted_index.extensive | 35 |
| abstract_inverted_index.important | 26 |
| abstract_inverted_index.increased | 252 |
| abstract_inverted_index.off-label | 36 |
| abstract_inverted_index.recommend | 75 |
| abstract_inverted_index.screened, | 160 |
| abstract_inverted_index.treatment | 22 |
| abstract_inverted_index.Authority. | 66 |
| abstract_inverted_index.COVID‑19 | 19, 189, 271 |
| abstract_inverted_index.Department | 69 |
| abstract_inverted_index.Ivermectin | 1, 45 |
| abstract_inverted_index.Regulatory | 65 |
| abstract_inverted_index.definitive | 268 |
| abstract_inverted_index.indicating | 152 |
| abstract_inverted_index.injectable | 48 |
| abstract_inverted_index.ivermectin | 17, 31, 79, 86, 153, 183, 262 |
| abstract_inverted_index.prevention | 20 |
| abstract_inverted_index.preventive | 266 |
| abstract_inverted_index.registered | 52 |
| abstract_inverted_index.supporting | 16 |
| abstract_inverted_index.veterinary | 197 |
| abstract_inverted_index.Background. | 0 |
| abstract_inverted_index.COVID‑19. | 13 |
| abstract_inverted_index.Information | 92 |
| abstract_inverted_index.Seventy-one | 157 |
| abstract_inverted_index.appropriate | 283 |
| abstract_inverted_index.conflicting | 40 |
| abstract_inverted_index.publication | 102, 151 |
| abstract_inverted_index.conflicting, | 24 |
| abstract_inverted_index.dichotomised | 146 |
| abstract_inverted_index.formulations | 49 |
| abstract_inverted_index.limitations. | 27 |
| abstract_inverted_index.preparations | 202 |
| abstract_inverted_index.significant, | 33 |
| abstract_inverted_index.symptomatic. | 224 |
| abstract_inverted_index.antiparasitic | 4 |
| abstract_inverted_index.formulations. | 284 |
| abstract_inverted_index.preparations, | 198 |
| abstract_inverted_index.preparations. | 207 |
| abstract_inverted_index.retrospective | 113 |
| abstract_inverted_index.dermatological | 245 |
| abstract_inverted_index.recommendations | 281 |
| abstract_inverted_index.gastrointestinal | 238 |
| abstract_inverted_index.Ivermectin-related | 249 |
| abstract_inverted_index.ivermectin-related | 115 |
| abstract_inverted_index.SARS-CoV-2.Methods. | 110 |
| abstract_inverted_index.SARS-CoV-2.Results. | 156 |
| abstract_inverted_index.systems.Conclusion. | 248 |
| abstract_inverted_index.COVID‑19.Objectives. | 81 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 9 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8700000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.51504573 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |